These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 11950918)
1. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Kahn HJ; Bailey D; Marks A Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918 [TBL] [Abstract][Full Text] [Related]
2. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Fukunaga M Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Folpe AL; Veikkola T; Valtola R; Weiss SW Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276 [TBL] [Abstract][Full Text] [Related]
4. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Galambos C; Nodit L Pediatr Dev Pathol; 2005; 8(2):181-9. PubMed ID: 15719202 [TBL] [Abstract][Full Text] [Related]
5. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma]. Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221 [TBL] [Abstract][Full Text] [Related]
6. Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40. Dubina M; Goldenberg G J Am Acad Dermatol; 2009 Aug; 61(2):276-80. PubMed ID: 19615538 [TBL] [Abstract][Full Text] [Related]
7. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations. Castro EC; Galambos C Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526 [TBL] [Abstract][Full Text] [Related]
8. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma. Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472 [TBL] [Abstract][Full Text] [Related]
10. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Miettinen M; Lindenmayer AE; Chaubal A Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718 [TBL] [Abstract][Full Text] [Related]
11. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Jussila L; Valtola R; Partanen TA; Salven P; Heikkilä P; Matikainen MT; Renkonen R; Kaipainen A; Detmar M; Tschachler E; Alitalo R; Alitalo K Cancer Res; 1998 Apr; 58(8):1599-604. PubMed ID: 9563467 [TBL] [Abstract][Full Text] [Related]
12. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Partanen TA; Alitalo K; Miettinen M Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384 [TBL] [Abstract][Full Text] [Related]
13. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. Uccini S; Ruco LP; Monardo F; Stoppacciaro A; Dejana E; La Parola IL; Cerimele D; Baroni CD J Pathol; 1994 May; 173(1):23-31. PubMed ID: 7523640 [TBL] [Abstract][Full Text] [Related]
14. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397 [TBL] [Abstract][Full Text] [Related]
15. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3. Parsons A; Sheehan DJ; Sangueza OP Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541 [TBL] [Abstract][Full Text] [Related]
16. Expression of PROX-1 in oral Kaposi's sarcoma spindle cells. Benevenuto de Andrade BA; Ramírez-Amador V; Anaya-Saavedra G; Martínez-Mata G; Fonseca FP; Graner E; Paes de Almeida O J Oral Pathol Med; 2014 Feb; 43(2):132-6. PubMed ID: 23763431 [TBL] [Abstract][Full Text] [Related]
17. Lymphatic differentiation in classic Kaposi's sarcoma: patterns of D2-40 immunoexpression in the course of tumor progression. Kandemir NO; Barut F; Gun BD; Keser SH; Karadayi N; Gun M; Ozdamar SO Pathol Oncol Res; 2011 Dec; 17(4):843-51. PubMed ID: 21479874 [TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212 [TBL] [Abstract][Full Text] [Related]
19. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Clarijs R; Schalkwijk L; Hofmann UB; Ruiter DJ; de Waal RM Cancer Res; 2002 Dec; 62(23):7059-65. PubMed ID: 12460927 [TBL] [Abstract][Full Text] [Related]